Illustrative image – not actual.Wockhardt would be commissioning its cephalosporin plant at Ankleshwar in Gujarat in January 2001. The 40 tonne capacity plant has been set up at a cost of Rs.35 crore. The plant has commenced trial production.
The plant would be used as an export oriented unit and 75 per cent of its production would be exported, while the remaining 25 per cent would be used for captive consumption under the domestic tariff area sales.
The company had faced several protests from non-governmental organisations on account of polluting practices by certain units located in the region, as a result of which the project was not cleared by state government. This in turn delayed the commissioning of the project.
